1121 related articles for article (PubMed ID: 18925838)
1. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
[TBL] [Abstract][Full Text] [Related]
3. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
4. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
5. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
[TBL] [Abstract][Full Text] [Related]
6. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
[TBL] [Abstract][Full Text] [Related]
7. Analysis of chosen polymorphisms rs2476601 a/G - PTPN22, rs1990760 C/T - IFIH1, rs179247 a/G - TSHR in pathogenesis of autoimmune thyroid diseases in children.
Rydzewska M; Góralczyk A; Gościk J; Wawrusiewicz-Kurylonek N; Bossowska A; Krętowski A; Bossowski A
Autoimmunity; 2018 Jun; 51(4):183-190. PubMed ID: 29973096
[TBL] [Abstract][Full Text] [Related]
8. Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.
Fathima N; Narne P; Ishaq M
Endocrine; 2019 Jun; 64(3):591-604. PubMed ID: 30771152
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 polymorphisms (+49 A/G and -318 C/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study.
Pastuszak-Lewandoska D; Domańska D; Rudzińska M; Bossowski A; Kucharska A; Sewerynek E; Czarnecka K; Migdalska-Sęk M; Czarnocka B
Acta Biochim Pol; 2013; 60(4):641-6. PubMed ID: 24364045
[TBL] [Abstract][Full Text] [Related]
10. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease.
Hiratani H; Bowden DW; Ikegami S; Shirasawa S; Shimizu A; Iwatani Y; Akamizu T
J Clin Endocrinol Metab; 2005 May; 90(5):2898-903. PubMed ID: 15741259
[TBL] [Abstract][Full Text] [Related]
11. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
[TBL] [Abstract][Full Text] [Related]
13. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients.
Akamizu T; Sale MM; Rich SS; Hiratani H; Noh JY; Kanamoto N; Saijo M; Miyamoto Y; Saito Y; Nakao K; Bowden DW
Thyroid; 2000 Oct; 10(10):851-8. PubMed ID: 11081251
[TBL] [Abstract][Full Text] [Related]
14. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population.
Liu L; Wu HQ; Wang Q; Zhu YF; Zhang W; Guan LJ; Zhang JA
Endocr J; 2012; 59(8):717-23. PubMed ID: 22673349
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
[TBL] [Abstract][Full Text] [Related]
17. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
[TBL] [Abstract][Full Text] [Related]
18. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
[TBL] [Abstract][Full Text] [Related]
19. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
20. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
